The VISION Laboratory, led by Dr Sarah Bohndiek operates jointly between the Department of Physics and the Cancer Research UK Cambridge Institute.
In the Physics laboratory, we develop and validate new imaging technologies. We currently focus on signal excitation in the visible and near infrared and aim to produce hyperspectral imaging methods with high sensitivity and specificity for clinical translation.
In the CRUK CI laboratory, we combine these new developments in molecular imaging with preclinical disease models to better understand cancer therapy response and drug resistance. In particular, we are interested in the role of oxygen, including the presence, absence and metabolism of oxygen in tumour cells and surrounding blood vessels.